Page last updated: 2024-09-05

24-norursodeoxycholic acid and icg 001

24-norursodeoxycholic acid has been researched along with icg 001 in 1 studies

Compound Research Comparison

Studies (24-norursodeoxycholic acid)	Trials (24-norursodeoxycholic acid)	Recent Studies (post-2010) (24-norursodeoxycholic acid)	Studies (icg 001)	Trials (icg 001)	Recent Studies (post-2010) (icg 001)
35	2	27	108	1	102

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ	1

Reviews

1 review(s) available for 24-norursodeoxycholic acid and icg 001

Article	Year
Crosstalk network among multiple inflammatory mediators in liver fibrosis. World journal of gastroenterology, 2019, Sep-07, Volume: 25, Issue:33 Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid	2019

Article

Year

Crosstalk network among multiple inflammatory mediators in liver fibrosis.

World journal of gastroenterology, 2019, Sep-07, Volume: 25, Issue:33

Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid

2019